← Back to Search

Intervention for Human Immunodeficiency Virus Infection

N/A
Waitlist Available
Led By Michael Wohlfeiler, MD
Research Sponsored by Epividian
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 9
Awards & highlights

Study Summary

This study is evaluating whether a system of alerts can help providers manage the scheduling of monthly cabotegravir + rilpivirine long-acting injections for the treatment of HIV.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability and usefulness of the intervention
Adherence to treatment-window
Secondary outcome measures
Number of CAB+RPV LA patients managed through the app
Number of clinics that use the App for the management of CAB+RPV LA patients

Trial Design

2Treatment groups
Active Control
Group I: InterventionActive Control1 Intervention
Clinics randomized to the intervention. A notification will be sent to the provider when a patient on CAB+RPV LA needs to be scheduled for their injections or when an appointment needs to be confirmed. Alerts are sent out to the provider when a patient is due or overdue for their injections.
Group II: ControlActive Control1 Intervention
Clinics randomized to the control group. No alerts or notification will be sent. The providers will manage their CAB+RPV LA patients using standard of care in their clinic.

Find a Location

Who is running the clinical trial?

EpividianLead Sponsor
7 Previous Clinical Trials
2,144,756 Total Patients Enrolled
AIDS Healthcare FoundationOTHER
17 Previous Clinical Trials
145,634 Total Patients Enrolled
ViiV HealthcareIndustry Sponsor
359 Previous Clinical Trials
468,506 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Cabenuva Injection Tracking in CHORUS
2021. "Cabenuva Injection Tracking in CHORUS". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04863261.
~11 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top